Lizzo Reveals the Diet Change That Helped Her Lose Weight Without Ozempic
As a four-time Grammy Award winner and fashion visionary with her inclusive shapewear brand Yitty, Lizzo has become a household name in the entertainment industry. The 'Truth Hurts' singer also speaks openly about body positivity not only in her lyrics, but in interviews and on social media, where she discussed her body confidence and weight loss journey. In a June 19 appearance on Trisha Paytas's podcast Just Trish, Lizzo opened up about the weight loss strategies that have worked for her—plus the ones she's opted out of.
In a September 2024 Instagram post, Lizzo shared a video with the caption, 'When you finally get Ozempic allegations after 5 months of weight training and calorie deficit,' addressing fans' questions on whether the type 2 diabetes drug played a role in her health journey.
In the Just Trish episode, Lizzo and Paytas discussed losing weight with Ozempic. Paytas said that pregnancy has prevented her from trying it, but after she gives birth to her third child she would consider using the medication. Paytas then asked Lizzo if she's ever tried any weight loss medication.
"I've tried everything,' Lizzo responded. 'It's just the science for me: calories in, versus calories out. Ozempic works because you eat less food. That's it. It makes you feel full. So if you can just do that on your own and get mind over matter, it's the same.'
Swapnil Patel, MD, MHCM, FACP, Vice Chairman of the Department of Medicine at Hackensack Meridian Jersey Shore University Medical Center, says that although medications can be helpful, nutrition plays a big role in weight loss.
'Many people are surprised by how much impact nutrition alone can have on their hunger, energy and weight when they shift toward higher-quality, whole foods,' says Dr. Patel. 'While medications can be a helpful tool for some, especially those with underlying metabolic conditions, others find that simplifying their eating habits and tuning in to natural hunger cues is more sustainable long-term. The key is keeping to what works for each individual's body and life.'
While Lizzo seems to generally follow a 'calories in, calories out' mindset, she's also adjusted her diet to make sure she's getting enough satiating calories vs. empty calories. Lizzo shared that while following a vegan diet in the past, she often didn't feel full despite consuming a high number of calories.
'When I was vegan, I was consuming a lot of fake meats," Lizzo said. "I was eating a lot of bread. I was eating a lot of rice. And I had to eat a lot of it to stay full. But really, I was consuming like 3,000 to 5,000 calories a day.'
She also opened up about the hidden calories and additives in foods that appeared healthy.
'We live in a society that makes super calorically-dense food and they hide it," Lizzo said. "So you're eating something that's small and you think, 'Oh yeah this is a healthy little protein bar.' It'll be like 300 calories and filled with all this fake sugar and weird s--- that f---- you up on the inside that you're not even aware of. Then you'd still be hungry.'
On the podcast, Lizzo shared that she followed a diet around plant foods for a decade before incorporating meat and seafood back into her diet. 'I think I was plant-based for like 10 years,' Lizzo said. 'And then really vegan from 2020 to 2023.'
While switching to a new dietary routine after so many years may seem difficult, Lizzo not only made the change, but found it helpful in kick-starting her weight loss. 'When I started actually eating whole foods and eating beef and chicken and fish, I was actually full and not expanding my stomach by putting a lot of like fake things in there that wasn't actually filling me up,' Lizzo said.
'When someone transitions from a highly-processed diet to one based on whole, minimally-processed foods, it can have a profound impact on their overall wellbeing,' says Dr. Patel. 'Whole foods are naturally richer in fiber, protein and essential nutrients—all of which support steadier blood sugar levels, more sustained energy and improved satiety.'
If you've found yourself struggling to feel full with seemingly healthy meals, a whole food diet could help.
'Whole foods tend to be more satiating because they're higher in fiber, water and volume that promote a sense of fullness,' says Dr. Patel. 'Additionally, they often require more chewing and digestion, triggering satiety hormones like GLP-1 and peptide YY. In contrast, ultra-processed foods are designed to be hyper-palatable and easy to over consume. They often bypass the body's natural satiety signals, which can lead to eating more without feeling full.'
Rather than focusing on weight loss, Lizzo has said she's on a 'weight release' journey—a 'very intentional' term that she said more accurately ecompasses the holistic changes she's making without negatively impacting her younger fans.
"My man, he's so funny,' said Lizzo of her boyfriend Mike Wright, as reported by People. 'He was the one that brought it to my attention at first. Because at first I was like, 'Oh my gosh I lost five pounds' and he was like, 'Where did it go?' It's like, I don't think I want to lose anything. I think I want to win. I think I want to gain.'
And in a January 2025 Instagram post, Lizzo shared that she reached her goal, reducing her body fat by 16 percent and lowering her body mass index (BMI) by 10.5 points. 'I did it,' she wrote. 'Today when I stepped on my scale, I reached my weight release goal. I haven't seen this number since 2014! Let this be a reminder you can do anything you put your mind to. Time for new goals!'
Keep scrolling for more celebrity weight loss stories!
Kelly Rowland Lost 70 Lbs in 4 Months With the 80/20 Rule—and She Never Calls It a 'Diet'
9 Celebrities Who Shared Their Weight Loss Secrets
How Adele Lost 100 Pounds Lifting Weights—'I Got Quite Addicted to It'
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
7 hours ago
- Newsweek
Ozempic Linked to Significant Reduction in Dementia—Study
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced risk of developing Alzheimer's disease-related dementia among patients with type 2 diabetes, a recent study reported. A new study published in the Journal of Alzheimer's Disease analyzed the medical records of over 1.7 million U.S. adults and found that semaglutide users experienced a notably lower risk of dementia compared to patients treated with insulin, metformin, or older GLP-1 agonists. These findings, publicly released on Tuesday, come as researchers and clinicians continue to search for effective means to mitigate the growing dementia epidemic in the U.S. Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. Photo by Steve Christo - Corbis/Corbis via Getty Images Why It Matters With over 6 million Americans diagnosed with dementia and more than 100,000 related deaths each year, the potential for semaglutide to meaningfully lower risk could have sweeping public health implications. Dementia does not have a cure, and nearly half of all cases are thought to be preventable by addressing risk factors like obesity, type 2 diabetes, and cardiovascular disease, the New York Post reported. Evidence supporting semaglutide's neuroprotective effects may inform future prevention strategies among high-risk populations in the U.S. What To Know Landmark Study Shows Sharp Risk Reduction Researchers at Case Western Reserve School of Medicine, National Institutes of Health and the MetroHealth System in Cleveland examined the health records of 1,710,995 U.S. patients with type 2 diabetes who had no prior diagnosis of Alzheimer's disease-related dementia (ADRD). The study used a statistical method simulating a randomized clinical trial, comparing dementia diagnoses among those prescribed semaglutide, insulin, metformin, and older GLP-1 receptor agonists. Patients treated with semaglutide had a 46 percent lower risk of developing ADRD than those receiving insulin, a 33 percent lower risk than those on metformin, and a 20 percent lower risk than those on earlier GLP-1 agonists. The effect was particularly pronounced for vascular dementia, one of the most common subtypes. No protective association was found for frontotemporal dementia or Lewy body dementia. Wide Demographic Impact Observed The protective association was consistent among subgroups, including younger and older patients, men and women, and those with and without obesity. Researchers found the risk reduction was especially evident among older adults and women. What is Semaglutide? Semaglutide is a glucagon-like peptide-1 receptor agonist that helps regulate blood sugar, lowers body weight, and offers cardiovascular benefits for patients with diabetes. The drug can help improve insulin sensitivity, protect blood vessels, and reduce inflammation in the brain. Important Study Limitations Authors acknowledged limitations, including reliance on administrative diagnosis codes, which are subject to underdiagnosis and misclassification, data on medication adherence, cognitive test scores, and genetic risk factors were unavailable. Variations in clinical practice and health care use variations could also affect findings. Researchers emphasized the need for preclinical and clinical studies to establish causal effects. Additional International Data A separate study by Oxford University, published in Lancet's eClinicalMedicine journal, analyzed more than 100 million U.S. medical records and found that Ozempic users experienced lower rates of cognitive decline and nicotine use compared to those on other diabetes medications. This study also did not find a higher risk of anxiety, depression, or other neurological and psychiatric conditions with Ozempic. The researchers emphasized that the results were limited to diabetic patients and require more rigorous randomized controlled trials. What People Are Saying The researchers of the study, in a news article published by the American Journal of Managed Care: "In a real-world population with T2D [type 2 diabetes] who had no prior diagnosis of AD/ADRD [Alzheimer disease/Alzheimer disease-related dementia], our study shows that semaglutide was associated with a significantly lower risk of overall ADRD incidence compared with other antidiabetic medications, including insulin, metformin, and other GLP-1RAs. Significant reductions were observed in older and younger patients, women and men, and patients with and without obesity." Howard Fillit, chief science officer of the Alzheimer's Drug Discovery Foundation, in comments to Reuters: "The answer to all those limitations is to do a randomized clinical trial, which is exactly what Novo is doing." What Happens Next Novo Nordisk, the maker of Ozempic, began testing semaglutide in patients with early Alzheimer's disease in 2021. The results are expected sometime this year. Do you have a story that Newsweek should be covering? Do you have any questions about this story? Contact LiveNews@
Yahoo
9 hours ago
- Yahoo
Police seize €57 million in illegal Ozempic, peptides, and other black market drugs in global bust
Police agencies worldwide seized $65 million (€57.2 million) worth of counterfeit or unapproved medicines in a major international bust that took aim at the deluge of cheap fakes sold online. Between December and May, authorities in 90 countries – including 16 in the European Union – confiscated 50.4 million doses of drugs that were either fake, misbranded, unapproved, or diverted, according to the International Criminal Police Organization (Interpol), which coordinated the operation. In Europe, many of the seizures were for counterfeit or unapproved weight loss drugs and peptide supplements, which Interpol said reflects the surging popularity of 'cosmetic and performance-enhancing' pharmaceuticals. These drugs are so widely available online and on social media that police are having a hard time keeping up, Alfonso Mejuto Rodríguez, Interpol's pro tempore assistant director of criminal networks, told Euronews Health. Related Rising deaths, fake pills, gang violence: How the EU is struggling to cope with illegal drug problem 'It's not even necessary to go to the dark web [because] there are a lot of advertisements online,' Rodríguez said. The drugs are marketed as 'good for your health, good for your image,' he added. 'That is exactly the risk for human health, because when you buy them, you are not really sure what they contain'. The World Health Organization (WHO) and European Medicines Agency (EMA) have both warned in recent years that the black market is flourishing for counterfeit semaglutide, which is the active ingredient in blockbuster anti-obesity and diabetes medicines such as Ozempic and Wegovy. Interpol said a single semaglutide pen can sell for hundreds of euros on the black market. Meanwhile, peptide seizures were relatively rare until recently. The agency said the uptick in Europe, North America, and Oceania reflects a rise in demand for supplements such as BPC-157, ipamorelin, and melanotan, which are unproven products sold illegally as wellness, anti-ageing, or cosmetic aids. Related Weight loss drugs: New study sheds light on illegal online pharmacies selling Wegovy and Ozempic Melanotan, for example, is a synthetic hormone designed to boost melanin production, giving people the appearance of tanned skin. Sometimes called the 'Barbie drug,' melanotan has taken off on platforms such as TikTok – but it is not regulated in Europe and health agencies have warned that it may cause serious health problems. 'With a lot of substances, the marketing is amplified by influencers, for instance in terms of health and culture,' Rodríguez said. Worldwide, the most commonly seized illicit pharmaceuticals were psychostimulants, anti-anxiety drugs, and Parkinson's disease medicines, followed by erectile dysfunction drugs, Interpol said. Other commonly seized counterfeit or otherwise illegal drugs include anabolic steroids, anti-smoking medicines, dermatological agents, health supplements, herbal products, and psychotropic medications for mental health conditions. Police also confiscated the opioid painkiller oxycodone in Bulgaria, France, Ireland, and Sweden. Related Fake painkillers are circulating in the Netherlands, authorities warn after man dies The sale of counterfeit medicines can have deadly consequences. In March, a 30-year-old man died after taking fake painkillers in the Netherlands, and last month, health authorities in Denmark warned that they were also circulating there. 'It seems that in the West, the demand for painkillers is rising… and criminals are taking advantage of it,' Rodríguez said. As part of the Interpol operation, nearly 800 suspects were arrested and 123 criminal groups were dismantled. Police also took down about 13,000 websites, social media accounts, and bots that advertised and sold illegal or counterfeit medicines online. Authorities in Ireland shuttered about 1,400 online listings for fake or illegal medicines, more than any other country except for Malaysia and Russia. Together with Singapore and Iran, the five countries accounted for 96 per cent of all listings that were taken down. Related Over 230 arrested as Europol dismantles four major drug smuggling networks Ireland also saw large seizures of illegal medicines, as did the Netherlands, Portugal, Spain, Sweden, and the United Kingdom, according to Interpol. In Portugal, for example, police discovered anabolic steroids in eight prisons, which Interpol said was evidence of a criminal smuggling network. The agency noted that Europe-based criminals have easy access to the raw materials and infrastructure needed to run counterfeit drug production networks, meaning they can quickly adapt to changing trends and demand from consumers. 'It's a challenge for law enforcement agencies to follow this activity,' Rodríguez said.
Yahoo
11 hours ago
- Yahoo
Kate Middleton's Cancer Struggle Reportedly More Intense Than Revealed
Kate Middleton's Cancer Struggle Reportedly More Intense Than Revealed originally appeared on Parade. Fifteen months after Kate Middleton bravely shared her cancer diagnosis with the world, new reports suggest her private health battle was reportedly more serious than previously revealed. This update comes in the wake of the Princess of Wales pulling out of a Royal Ascot appearance at the last minute, raising fresh concerns about her condition and sparking renewed speculation about her recovery. Royal editor and insider Rebecca English penned an essay for The Daily Mail, addressing these concerns. She claimed the princess was "seriously unwell" before her surgery in January 2024. English speculated, "As I have previously revealed, the princess was seriously unwell in the run-up to her surgery in the first place. And while that is a story only for her to tell, if she ever chooses to do so." "I can say that, from what I understand, she is fortunate to even be speaking of recovery. So, while she may be glowing on the outside, the drama over her last-minute non-attendance at Royal Ascot last week is, perhaps, a timely reminder that the princess was really very poorly not so long ago." Parade Daily🎬 SIGN UP for Parade's Daily newsletter to get the latest pop culture news & celebrity interviews delivered right to your inbox 🎬 The palace revealed that the Princess of Wales underwent a scheduled abdominal surgery in January 2024. She addressed her health in March of that same year when she took to social media to share a video statement. Subsequently, Kate took on her first official engagement, 2024's Trooping the Color, six months after her surgery. She continued to maintain a light schedule throughout the remainder of the year. In January 2025, the princess announced she was in remission during an appearance at the Royal Marsden Hospital. Her statement was printed via Instagram. During the same appearance, Kate opened up further about her cancer treatment while speaking with fellow patients. The Daily Mail captured a portion of the Princess's conversation, offering a rare glimpse into her health journey. "You think treatment's finished, crack on with that… daily tasks, but that's still like a real challenge. And talking… the words totally disappear… understanding that as a patient, yes there are side effects around treatment, but actually there are more long-term side effects." While speaking with a patient, the Princess of Wales gestured to her arm and chest. She appeared to reference the port used to deliver her chemotherapy treatment. 'I got so attached to it,' the Princess revealed. Additionally, she shared her hesitation when doctors said, 'You can have it taken out now.' Kate Middleton continues to keep a modified royal schedule. She is married to Prince William and is the mother of three children, Prince George, Princess Charlotte, and Prince Louis. Kate Middleton's Cancer Struggle Reportedly More Intense Than Revealed first appeared on Parade on Jun 25, 2025 This story was originally reported by Parade on Jun 25, 2025, where it first appeared.